Add office photos
Engaged Employer
SAI Life Sciences
3.9
based on 1.1k Reviews
Video summary
Company Overview
Company Locations
Working at SAI Life Sciences
Company Summary
SAI Life Sciences collaborates with pharmaceutical and biotech firms to expedite the development and manufacturing of complex molecules in the healthcare industry.
Overall Rating
3.9/5
based on 1.1k reviews
On-Par with
industry average
Highly rated for
Salary, Company culture, Skill development
Critically rated for
Promotions
Work Policy
Work from office
80% employees reported
Monday to Friday
43% employees reported
Flexible timing
54% employees reported
No travel
48% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
95 employees reported
Job/Soft skill training
72 employees reported
Cafeteria
58 employees reported
Health insurance
40 employees reported
View all benefits
About SAI Life Sciences
Founded in1999 (26 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
India HeadquartersHyderabad, India
Office Locations
Websitesailife.com
Primary Industry
Other Industries
View in video summary
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
Mission: Sai provides services to our pharma innovator partners, which accelerate discovery, development and manufacture of complex small molecules. Sai commits to being reliable, fully compliant and continuously get better at every aspect of our service.
Vision: Sai Life Sciences will facilitate launch of 25 new medicines by our global innovator partners through 2025 and achieve $250 million in annual revenue. For our employees, we will cultivate a stimulating work environment and become one of the top 3 CDMO’s to work for by 2020. Our actions are guided by a culture of integrity and respect while embracing our social responsibility.
SAI Life Sciences Ratings
based on 1.1k reviews
Overall Rating
3.9/5
How AmbitionBox ratings work?
5
450
4
381
3
146
2
72
1
93
Category Ratings
3.9
Salary
3.8
Company culture
3.8
Skill development
3.7
Work-life balance
3.6
Job security
3.6
Work satisfaction
3.3
Promotions
SAI Life Sciences is rated 3.9 out of 5 stars on AmbitionBox, based on 1.1k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at SAI Life Sciences
based on 1.1k reviews
3.8
Rated by 120 Women
Rated 3.7 for Company culture and 3.7 for Job security
4.0
Rated by 993 Men
Rated 3.9 for Salary and 3.9 for Skill development
Work Policy at SAI Life Sciences
based on 193 reviews in last 6 months
Work from office
80%
Hybrid
18%
Permanent work from home
2%
SAI Life Sciences Reviews
Top mentions in SAI Life Sciences Reviews
+ 5 more
Compare SAI Life Sciences with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.9/5 based on 1.1k reviews | 4.0/5 based on 1.5k reviews | 3.9/5 based on 2k reviews | 3.9/5 based on 4.2k reviews |
Highly Rated for | Salary Skill development Company culture | Job security Company culture Skill development | Job security Company culture Skill development | Job security Work-life balance Company culture |
Critically Rated for | Promotions | No critically rated category | Promotions | Promotions |
Primary Work Policy | Work from office 80% employees reported | Work from office 94% employees reported | Work from office 85% employees reported | Hybrid 71% employees reported |
Rating by Women Employees | 3.8 Good rated by 120 women | 3.9 Good rated by 226 women | 3.7 Good rated by 364 women | 3.9 Good rated by 1.7k women |
Rating by Men Employees | 4.0 Good rated by 993 men | 4.0 Good rated by 1.2k men | 4.0 Good rated by 1.5k men | 3.8 Good rated by 2.3k men |
Job security | 3.6 Good | 4.0 Good | 4.0 Good | 3.9 Good |
View more
SAI Life Sciences Salaries
SAI Life Sciences salaries have received with an average score of 3.9 out of 5 by 1.1k employees.
Research Chemist
(320 salaries)
Unlock
₹2.5 L/yr - ₹6.4 L/yr
Executive Production
(230 salaries)
Unlock
₹2.6 L/yr - ₹5.4 L/yr
Research Associate
(211 salaries)
Unlock
₹2.7 L/yr - ₹9.5 L/yr
Senior Research Associate
(169 salaries)
Unlock
₹4.5 L/yr - ₹13.4 L/yr
Senior Research Chemist
(155 salaries)
Unlock
₹3.6 L/yr - ₹8.1 L/yr
Associate Research Scientist
(135 salaries)
Unlock
₹6.5 L/yr - ₹14 L/yr
Deputy Manager
(126 salaries)
Unlock
₹7 L/yr - ₹16.1 L/yr
Research Scientist
(84 salaries)
Unlock
₹6.2 L/yr - ₹16.6 L/yr
Research Assistant
(64 salaries)
Unlock
₹2.5 L/yr - ₹6.5 L/yr
Process Engineer
(46 salaries)
Unlock
₹3 L/yr - ₹7.4 L/yr
SAI Life Sciences Interview Questions
Interview questions by designation
Top SAI Life Sciences interview questions and answers
Get interview-ready with top interview questions
SAI Life Sciences Jobs
Popular Skills SAI Life Sciences Hires for
Current Openings
SAI Life Sciences News
View all
Stock Recommendations Today: Tata Motors, Waaree Energies, Patanjali On Brokerages' Radar
- Tata Motors, Waaree Energies, and Patanjali Foods are in focus for brokerages, with various ratings and target prices discussed.
- HSBC upgraded Tata Motors to 'buy' from 'hold' with a reduced target price, citing growth triggers in margin expansion and recovery in business sectors.
- Jefferies initiated a 'hold' rating for Waaree Energies, highlighting the benefits from policy tailwinds but cautioning about potential oversupply challenges by 2028.
- Patanjali received a 'buy' rating from Jefferies, emphasizing its diversified consumer franchise, acquisition strategies, and expected growth in revenue and margins.
- Sai Life Sciences garnered a 'hold' rating from Jefferies, noting its track record and growth potential but stating limited upside due to high current valuation.
- JSW Energy maintained a 'buy' rating with an increased target price, projecting improved financial performance and growth in Ebitda in the coming years.
- BofA kept a 'buy' rating for Bajaj Auto, foreseeing growth opportunities in new segments, domestic volumes, and exports in the near future.
- Citi upgraded Gujarat State Petronet to 'buy', citing positive developments with a new pipeline project and potential tariff benefits in the long term.
- Overall, brokerages provide insights on these companies, highlighting growth prospects, challenges, and investment recommendations for investors to consider.
- Stay updated on stock recommendations and market trends with NDTV Profit's analyst calls and expert opinions.
Bloomberg Quint | 17 Mar, 2025
Mobikwik To Vishal Mega Mart: Shares Worth Rs 3,500 Crore To Exit Lock-Ins Next Week
- Shares worth over Rs 3,500 crore, including those of One Mobikwik Systems Ltd. and Vishal Mega Mart Ltd., are set to exit their respective lock-in periods next week.
- 6% of equity for One Mobikwik Systems is set to become eligible for trade as they exit the second lock-in expiry period for anchor investors.
- Vishal Mega Mart will see the largest value of shares becoming free to trade on March 17 at Rs 1,527 crore.
- Shares of Sai Life Sciences Ltd. and Inventurus Knowledge Solutions Ltd. are also set to exit their lock-in periods.
Bloomberg Quint | 13 Mar, 2025
Stock Market Today: All You Need To Know Going Into Trade On Feb. 21
- The NSE Nifty 50 and BSE Sensex closed lower on Thursday, with underperformance in financial heavyweights like HDFC Bank Ltd. and ICICI Bank Ltd.
- Foreign portfolio investors were net sellers while domestic institutional investors continued buying streak for the 12th session.
- The Indian rupee strengthened against the US dollar, closing at Rs 86.66 per dollar.
- Earnings post market hours showed mixed results with CIE Automotive and Sanofi Consumer reporting changes in revenue, Ebitda, and net profit.
- Stocks to watch include JM Financial, NTPC Green Energy, Vedanta, Religare Enterprises, Cipla, and more as they make significant announcements.
- Bulk deals and insider trading activities were highlighted for companies like Isgec Heavy Engineering, Sai Life Sciences, and others.
- Listing day for Quality Power Electrical Equipments is set for Friday after a successful IPO subscription rate.
- Trading tweaks included companies moving in and out of the Short-Term ASM Framework, F&O cues, and research reports from ICICI Securities, Anand Rathi, DRChoksey, and more.
- Overall, the stock market today reflected a mix of company performances, investor activities, and future outlooks.
- For more updates, viewers can watch live TV, get stock market updates, top business, IPO news on NDTV Profit.
Bloomberg Quint | 21 Feb, 2025
Sai Life Sciences Shares End At 40% Premium Over Issue Price
- The share price of Sai Life Sciences Ltd. ended at Rs 768.4 apiece, a premium of 39.9% over the issue price of Rs 549 apiece.
- The IPO was subscribed 10.26 times on its final day, with qualified institutional buyers leading the bids.
- Sai Life Sciences is a contract research, development, and manufacturing organization catering to global pharmaceutical and biotechnology companies.
- The IPO proceeds will be used for debt payment and corporate general purposes.
Bloomberg Quint | 18 Dec, 2024
TPG Capital-backed Sai Life Sciences to list today
- Sai Life Sciences, backed by TPG Capital, is set to list today.
- Promoter entity Sai Quest Syn Private Ltd, along with TPG Asia VII SF Pte Ltd and HBM Private Equity India, will divest part of their stakes through an offer for sale (OFS) process.
- The qualified institutional buyer (QIB) portion of the IPO was subscribed 30.93 times, while the retail investor and high net worth individual (HNI) quota were subscribed 1.37 times and 4.92 times, respectively.
- The IPO proceeds will be used for debt repayment and general corporate purposes, with ₹600 crore allocated for debt repayment.
HinduBusinessLine | 18 Dec, 2024
Sai Life Sciences Shares Debut At 19% Premium Over Issue Price
- The share price of Sai Life Sciences Ltd. listed on the BSE and NSE at a premium of 20.2% and 18.4% respectively over the issue price.
- The Sai Life Sciences IPO was subscribed 10.26 times on its final day, with qualified institutional buyers leading the bids.
- The IPO included a fresh issue of 1.73 crore shares worth Rs 950 crore and an offer for sale of 3.81 crore shares.
- Sai Life Sciences is an innovator-focused contract research and manufacturing organization, offering comprehensive services across the drug discovery and development value chain.
Bloomberg Quint | 18 Dec, 2024
Premium Or Discount Listing? What GMP Of Vishal Mega Mart, Mobikwik And Sai Life Sciences IPOs Suggests
- The IPOs of Vishal Mega Mart, Mobikwik, and Sai Life Sciences have closed for subscription and are set to list on the BSE and NSE on Dec. 18.
- Investors can check the grey market premium (GMP) for a rough estimate of the possible listing price.
- Vishal Mega Mart IPO has a GMP of Rs 20.50 with a projected listing gain of 26.28%.
- MobiKwik IPO has a GMP of Rs 165 with a projected listing gain of 59.14%.
Bloomberg Quint | 17 Dec, 2024
Check Sai Life Sciences IPO GMP Ahead Of Share Allotment Today; Find Steps To Verify Status
- The grey market premium of the Sai Life Sciences IPO was Rs 50 as of 5:03 am on December 16.
- Investors who bid in Sai Life Sciences IPO now await the finalisation of the share allotment status.
- Sai Life Sciences IPO share allotment will be finalised on December 16 following a successful three-day bidding period.
- Investors can check the share allotment status on BSE, NSE, and KFin Technologies Ltd's websites.
Bloomberg Quint | 16 Dec, 2024
Sai Life Sciences issue garners bids for 10.26 times
- Sai Life Sciences issue garnered bids for 10.26 times in the Offer For Sale (OFS).
- The QIB portion was subscribed 30.93 times, while retail and HNI quotas were subscribed 1.37 times and 4.92 times respectively.
- The company raised ₹913 crore from anchor investors as part of the IPO process, allocating equity shares to 63 funds.
- The IPO proceeds will be used for debt repayment and general corporate purposes.
HinduBusinessLine | 13 Dec, 2024
Sai Life Sciences IPO Subscribed 1.65 Times So Far On Final Day
- The Sai Life Sciences IPO has been subscribed 1.65 times on the final day.
- The company aims to raise Rs 3,042 crore via the IPO.
- The IPO includes a fresh issue of 1.73 crore shares worth Rs 950 crore and an offer for sale of 3.81 crore shares totalling Rs 2,092.6 crore.
- The funds raised will be utilized for debt repayment and general corporate purposes.
Bloomberg Quint | 13 Dec, 2024
Powered by
SAI Life Sciences Offices
Compare SAI Life Sciences with
Parexel International
3.8
Fortrea Development India Private Limited
3.9
ICON Plc
4.1
Syneos Health
3.8
Qinecsa Solutions
2.9
Reliance Life Sciences
3.6
Rubicon Research
3.5
Veeda Clinical Research
3.8
Aizant Drug Research Solutions
3.8
Lambda Therapeutic Research
4.3
Navitas Life Sciences
3.4
Cliantha Research
3.9
Accutest Research Laboratories
3.4
Perceptive
3.5
ClinChoice
4.0
Clario
4.0
Waters Corporation
3.9
Cytel Statistical Software & Services
4.4
National Environmental Engineering Research Institute
4.4
National Chemical Laboratory
4.2
Contribute & help others!
You can choose to be anonymous
Companies Similar to SAI Life Sciences
IQVIA
Consulting, Healthcare / Pharma, Internet, Analytics & KPO, Clinical Research, Healthcare, Pharma
3.9
• 4.2k reviews
Syngene International
Clinical Research
3.9
• 2k reviews
Aragen Life Sciences
Biotech & Life sciences, Analytics & KPO, Clinical Research
4.0
• 1.5k reviews
Parexel International
Healthcare / Pharma, Manufacturing, Analytics & KPO, Clinical Research, Pharma
3.8
• 974 reviews
Fortrea Development India Private Limited
Biotech & Life sciences, Analytics & KPO, Clinical Research
3.9
• 753 reviews
ICON Plc
Biotech & Life sciences, Clinical Research, Pharma
4.1
• 770 reviews
Syneos Health
Biotech & Life sciences, Analytics & KPO, Clinical Research
3.8
• 617 reviews
Qinecsa Solutions
Biotech & Life sciences, Clinical Research, Pharma
2.9
• 730 reviews
Reliance Life Sciences
Financial Services, Clinical Research
3.6
• 422 reviews
Rubicon Research
Internet, Clinical Research, Pharma
3.5
• 260 reviews
Veeda Clinical Research
Clinical Research, Pharma
3.8
• 298 reviews
Aizant Drug Research Solutions
Analytics & KPO, Clinical Research
3.8
• 340 reviews
SAI Life Sciences FAQs
When was SAI Life Sciences founded?
SAI Life Sciences was founded in 1999. The company has been operating for 26 years primarily in the Clinical Research sector.
Where is the SAI Life Sciences headquarters located?
SAI Life Sciences is headquartered in Hyderabad. It operates in 3 cities such as Bidar, Bangalore / Bengaluru, Hyder. To explore all the office locations, visit SAI Life Sciences locations.
How many employees does SAI Life Sciences have in India?
SAI Life Sciences currently has more than 2,700+ employees in India. Research & Development department appears to have the highest employee count in SAI Life Sciences based on the number of reviews submitted on AmbitionBox.
Does SAI Life Sciences have good work-life balance?
SAI Life Sciences has a Work-Life Balance Rating of 3.7 out of 5 based on 1,100+ employee reviews on AmbitionBox. 73% employees rated SAI Life Sciences 4 or above, while 27% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read SAI Life Sciences work-life balance reviews for more details
Is SAI Life Sciences good for career growth?
Career growth at SAI Life Sciences is rated as moderate, with a promotions and appraisal rating of 3.3. 27% employees rated SAI Life Sciences 3 or below, while 73% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading SAI Life Sciences promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in SAI Life Sciences?
Working at SAI Life Sciences comes with several advantages and disadvantages. It is highly rated for salary & benefits, company culture and skill development. However, it is poorly rated for promotions / appraisal, based on 1,100+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
